Literature DB >> 16878063

The use of methylprednisolone versus diclofenac in the treatment of inflammation and trismus after surgical removal of lower third molars.

Carmen López Carriches1, José Ma Martínez González, Manuel Donado Rodríguez.   

Abstract

OBJECTIVE: To compare the efficacy of methylprednisolone (corticoid) versus diclofenac (nonsteroidal anti-inflammatory--NSAID) in the treatment of inflammation and trismus after the surgical removal of lower third molars. STUDY
DESIGN: Prospective study on 73 patients for the surgical removal of their lower third molars. These patients were separated in two groups at random: the diclofenac group and the methylprednisolone group. A record card was filled in with preoperative and postoperative epidemiological and clinic data about inflammation and trismus (three facial measures and mouth opening). In order to make a broad study of data, BMDP program was used for statistics.
RESULTS: 24 hours after surgery, patients in the diclofenac group showed a more severe inflammation in one of the facial measurements (<0.05). Trismus was very similar in both groups.
CONCLUSIONS: There were no differences in trismus depending on the antiinflammatory used. Patients in the corticoid group showed less inflammation but the difference was not as important as to justify their use.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16878063

Source DB:  PubMed          Journal:  Med Oral Patol Oral Cir Bucal        ISSN: 1698-4447


  8 in total

Review 1.  Efficacy of Methylprednisolone Compared to Other Drugs for Pain, Swelling, and Trismus Control after Third Molar Surgery: A Meta-Analysis.

Authors:  Mariana González-Morelos; Lorenzo Franco-de la Torre; Diana Laura Franco-González; Eduardo Gómez-Sánchez; Ángel Josabad Alonso-Castro; Nelly Molina-Frechero; Luis Miguel Anaya-Esparza; Mario Alberto Isiordia-Espinoza
Journal:  Healthcare (Basel)       Date:  2022-06-01

2.  A Comparative Study of the Effect of Prednisolone and Celecoxib on MMO (Maximum Mouth Opening) and Pain Following Removal of Impacted Mandibular Third Molars.

Authors:  Ali Akbar Moghaddamnia; Kamran Nosrati; Mohammad Mehdizadeh; Shabnam Milani; Maral Aghvami
Journal:  J Maxillofac Oral Surg       Date:  2012-08-24

3.  Comparison of the anti-inflammatory effect of dexamethasone and ketorolac in the extractions of third molars.

Authors:  Janayna Gomes Paiva-Oliveira; Paulo Roberto Haidamus Oliveira Bastos; Elenir R J Cury Pontes; Júlio César Leite da Silva; Jéssica Andréa Berto Delgado; Nelson Talatoci Oshiro-Filho
Journal:  Oral Maxillofac Surg       Date:  2015-11-16

4.  Beneficial effect of methylprednisolone after mandibular third molar surgery: a randomized, double-blind, placebo-controlled split-mouth trial.

Authors:  Stephan Acham; Arnold Klampfl; Astrid Truschnegg; Robert Kirmeier; Andreas Sandner-Kiesling; Norbert Jakse
Journal:  Clin Oral Investig       Date:  2012-10-30       Impact factor: 3.573

5.  Effectiveness of submucosal dexamethasone to control postoperative pain & swelling in apicectomy of maxillary anterior teeth.

Authors:  Shahzad Ali Shah; Irfanullah Khan; Humera Shahzad Shah
Journal:  Int J Health Sci (Qassim)       Date:  2011-07

6.  Evaluation of the anaesthetic properties and tolerance of 1:100,000 articaine versus 1:100,000 lidocaine. A comparative study in surgery of the lower third molar.

Authors:  N Martínez-Rodríguez; C Barona-Dorado; M Martín-Arés; J Cortés-Bretón-Brinkman; J-M Martínez-González
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2012-03-01

7.  In search of a better option: dexamethasone versus methylprednisolone in third molar impaction surgery.

Authors:  Dattatraya A Darawade; Santosh Kumar; Rupal Mehta; Anant Raghav Sharma; G Sharaschandra Reddy
Journal:  J Int Oral Health       Date:  2014 Nov-Dec

8.  Sub-mucosal Dexamethasone for Post-operative Pain and Oedema Control in Lower Third Molar Surgery.

Authors:  Yogiraj B Virkar; Jitendra Chawla; Arindom Changmai; Krishna Kumar; Kumar Abhishek; Moazzam Jawaid
Journal:  J Pharm Bioallied Sci       Date:  2022-07-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.